Roberto Di Virgilio
-
- Antibiotic Use and Resistance 2
- Molecular Medicine top 10%
- Antibiotic Resistance in Bacteria 4
-
- Antibiotics Pharmacokinetics and Efficacy 2
-
- Health Systems, Economic Evaluations, Quality of Life 6
- Pharmaceutical Economics and Policy 3
-
- Pneumonia and Respiratory Infections 5
-
- Bone health and treatments 4
-
- Atrial Fibrillation Management and Outcomes 3
- Co-authors
- Patrizia BertoPierfrancesco RuffoThitima KongnakornClaudie CharbonneauAnna IulianoNathalie Baillon-PlotMatteo BassettiFederico Spandonaro
- Journals
- Value in Health (3 papers)Cardiovascular Therapeutics (1 paper)Journal of Orthopaedics and Traumatology (1 paper)
- Partner nations
- ItalyUnited StatesFrance
In The Last Decade
Roberto Di Virgilio
21 papers receiving 285 citations
Peers
Comparison fields: 5 of 80
- Applied Microbiology and Biotechnology 27
- Molecular Medicine 37
- Applied Psychology 26
- Pharmacology 58
- Social Psychology 57
Countries citing papers authored by Roberto Di Virgilio
This map shows the geographic impact of Roberto Di Virgilio's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Roberto Di Virgilio with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Roberto Di Virgilio more than expected).
Fields of papers citing papers by Roberto Di Virgilio
This network shows the impact of papers produced by Roberto Di Virgilio. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Roberto Di Virgilio. The network helps show where Roberto Di Virgilio may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Roberto Di Virgilio, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2024 | 0 | |
| 3 | 2023 | 0 | |
| 4 | 2023 | 8 | |
| 5 | 2022 | 10 | |
| 6 | 2020 | 15 | |
| 7 | 2020 | 11 | |
| 8 | 2019 | 16 | |
| 9 | 2019 | 14 | |
| 10 | 2017 | 2 | |
| 11 | 2017 | 6 | |
| 12 | 2016 | 2 | |
| 13 | 2015 | 19 | |
| 14 | 2014 | 1 | |
| 15 | 2014 | 1 | |
| 16 | 2002 | 4 | |
| 17 | 2000 | 151 | |
| 18 | 1994 | 8 | |
| 19 | 1991 | 3 | |
| 20 | [Observations on the morphology of tubercular mycobacteria studied by the electron microscope]. | 1960 | 0 |
About Roberto Di Virgilio
Roberto Di Virgilio is a scholar working on Applied Microbiology and Biotechnology, Molecular Medicine and Microbiology, having authored 26 papers that have together received 310 indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (6 papers), Pneumonia and Respiratory Infections (5 papers), Bone health and treatments (4 papers), Antibiotic Resistance in Bacteria (4 papers), Atrial Fibrillation Management and Outcomes (3 papers), Pharmaceutical Economics and Policy (3 papers), Antibiotic Use and Resistance (2 papers) and Antibiotics Pharmacokinetics and Efficacy (2 papers). The work is most often cited by research in Applied Microbiology and Biotechnology (27 citations), Molecular Medicine (37 citations) and Applied Psychology (26 citations). Roberto Di Virgilio has collaborated with scholars based in Italy, United States and France. Frequent co-authors include Patrizia Berto, Pierfrancesco Ruffo, Thitima Kongnakorn, Claudie Charbonneau, Anna Iuliano, Nathalie Baillon-Plot, Matteo Bassetti, Federico Spandonaro, Giancarlo Icardi and Ignazio Roiter. Their work appears in journals such as Value in Health, Cardiovascular Therapeutics, Journal of Orthopaedics and Traumatology, Chemotherapy and International Journal of Antimicrobial Agents.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.